QINGSONG HEALTH (02661) announced its financial results for 2025. Revenue reached approximately RMB1.256 billion, representing a year-on-year increase of 32.9%. Gross profit grew by 20.3% to RMB435 million, while adjusted net profit rose by 9.0% to RMB92 million.

Revenue from health-related services surged by 50.2% to RMB926 million, driven primarily by increased demand for digital marketing services and early disease screening promotion and consulting services. Income from insurance-related services increased by 1.6% to RMB326.5 million, mainly due to growth in insurance technology services.

In terms of user metrics, the company’s platform had over 168.6 million registered users as of December 31, 2025. The cumulative fan base through WeChat official accounts, mini-programs, and enterprise WeChat accounts reached approximately 63.8 million, up 4.9% from the end of 2024.

The platform’s health content offerings continued to expand. Supported by the i-Odin content creation platform, the company has accumulated over 1.2 million pieces of health content. Views of educational content also increased significantly, rising by 238.1% compared to the previous year.

Regarding its corporate partner ecosystem, the company collaborated with 103 pharmaceutical partners by the end of 2025, an increase of 66.1% from the end of 2024. Partnerships with insurance companies also grew, reaching 59, up 63.9% year-on-year.